Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2002
DOI: 10.1021/ja025870q
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro Selection for Catalytic Activity with Ribosome Display

Abstract: We report what is, to our knowledge, the first in vitro selection for catalytic activity based on catalytic turnover by using ribosome display, a method which does not involve living cells at any step. RTEM-beta-lactamase was functionally displayed on ribosomes as a complex with its encoding mRNA. We designed and synthesized a mechanism-based inhibitor of beta-lactamase, biotinylated ampicillin sulfone, appropriate for selection of catalytic activity of the ribosome-displayed beta-lactamase. This derivative of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
34
0
1

Year Published

2003
2003
2018
2018

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 74 publications
(36 citation statements)
references
References 59 publications
1
34
0
1
Order By: Relevance
“…The originally identified BLIP (from Streptomyces clavuligerus) 9 has become a model for a broad range of structural, mutagenic, biophysical, and computational studies. [10][11][12][13][14][15][16][17][18][19][20][21] BLIP has two close probable homologues: BLIP-I (from Streptomyces exfoliatus) and β-lactamase-inhibitoryprotein-like protein (BLP; S. clavuligerus). No other related protein † is found in any Streptomyces genome that has been sequenced fully ‡ or partially §.…”
Section: Introductionmentioning
confidence: 99%
“…The originally identified BLIP (from Streptomyces clavuligerus) 9 has become a model for a broad range of structural, mutagenic, biophysical, and computational studies. [10][11][12][13][14][15][16][17][18][19][20][21] BLIP has two close probable homologues: BLIP-I (from Streptomyces exfoliatus) and β-lactamase-inhibitoryprotein-like protein (BLP; S. clavuligerus). No other related protein † is found in any Streptomyces genome that has been sequenced fully ‡ or partially §.…”
Section: Introductionmentioning
confidence: 99%
“…The solution was incubated with 100 ml butylSepharose for one hour at 4 8C and the supernatant containing the ternary complexes was then applied to a gel filtration column to exchange the buffer to WBKT. 43 Selection of binders to Nogo-66 was performed for one hour at 4 8C by adding half of the eluted ternary complexes to 10 7 paramagnetic beads coated with either pD-Nogo-66 or Trx-Nogo-66 in the presence of BSA (final concentration 5 mg/ml) and Saccharomyces cerevisiae RNA (final concentration 250 mg/ml). After washing, RNA elution and purification, reverse transcription (RT) was performed with the Thermoscript-Kit (Invitrogen) and primer rdN2_L (5 0 -GGCGCGGTTGCGGTACCCATAG-3 0 ), including a RNaseH digestion step after the RT reaction.…”
Section: In Vitro Selection By Ribosome Displaymentioning
confidence: 99%
“…Retrieval of the complexes with the mechanism-based inhibitor, ampicillin sulfone, immobilized on magnetic beads provided a simple method to separate active conjugates. Testing ribosome display with an entire ␤-lactamase library is pending, but initial results of 100-fold per cycle enrichment factors indicate that this method may be an attractive system for future development of novel ␤-lactamase enzymes [91,92].…”
Section: Ribosome Displaymentioning
confidence: 99%